Search results for: rare disease

The highly specialised technologies (HST) process was introduced in 2013 for the purpose of evaluati...

If the French government is able to deliver, pharmaceutical companies can look forward to potentiall...

Orphan drugs have important societal value as they improve patient quality of life and address unmet...

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

X/Twitter

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Email Address(Required)

Phone(Required)

This field is hidden when viewing the form

Job Title(Required)

Which category are you most interested in receiving content on?(Required)

Consent

I agree to be contacted with relevant content and news

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.

Remap Consulting GmbH
Industriestrasse 47
Postfach 7461
6302 Zug
Switzerland

Remap Consulting UK Ltd
1F43, Mereside
Alderley Park
Cheshire
SK10 4TG